Merrill Goozner. Show Affiliations »
Abstract
Mesh： See more » Advisory CommitteesAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedAntineoplastic Agents/therapeutic useBevacizumabCelecoxibCetuximabControlled Clinical Trials as TopicDrug Approval/methodsDrug IndustryDrugs, Investigational/therapeutic useEuropeEvidence-Based MedicineHumansPanitumumabPyrazoles/therapeutic useSulfonamides/therapeutic useUnited StatesUnited States Food and Drug Administration
Substances： See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntineoplastic AgentsDrugs, InvestigationalPyrazolesSulfonamidesBevacizumabPanitumumabCelecoxibCetuximab
Year: 2011 PMID： 21393609 DOI： 10.1093/jnci/djr087
Source DB: PubMed Journal: J Natl Cancer Inst ISSN： 0027-8874 Impact factor: 13.506